Lineage Cell Therapeutics Inc (STU:BT3)
€ 0.95 +0.031 (+3.39%) Market Cap: 244.93 Mil Enterprise Value: 202.38 Mil PE Ratio: 0 PB Ratio: 4.69 GF Score: 77/100

Lineage Cell Therapeutics Inc (STU:BT3) Transcripts

  • 1